The clinical trial information on this page is intended for healthcare professionals.
The goal of clinical research is to help people live longer, healthier lives. To achieve this, researchers develop drugs that are designed to prevent or improve the treatment of diseases. Clinical studies test investigational or approved drugs.
During a clinical study, researchers aim to find out whether an investigational drug:
Clinical trials have four main phases, each with a specific goal. Phase 1 and 2 studies may look at whether an investigational drug may be safe or if it may cause side effects. Phase 3 studies may compare the investigational drug with other treatments already approved for the same purpose.
When the investigational drug has passed 3 phases, the results are reviewed by regulatory authorities to determine whether the treatment can be approved for patients. Although the drug may be approved for use, it still needs to be monitored. During the final phase, researchers test how well the drug works over a longer time period.
The ELEGANT study is testing an investigational use of elacestrant, a drug that
has already been approved to treat certain people with advanced breast cancer (cancer that has spread to other parts of the body). Researchers will be testing whether the same investigational use could work for people with early-stage breast cancer.
The ELEGANT Study is in Phase 3.
Clinical studies take place in clinics, hospitals, or other healthcare facilities. During a clinical study, you will be supported by a dedicated team of researchers, doctors, and nurses. Each member of the study team is committed to your safety and well-being.
By selecting the button below you acknowledge you are leaving the ELEGANT Study website and continuing to another website not covered under the ELEGANT Study’s website privacy policy.
Proceed to website
